We are live on ! Find out more
CT

Cambridge Trust Portfolio holdings

AUM $2.64B
1-Year Est. Return 28.73%
This Fund
S&P 500
This Quarter Est. Return
-2.89%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.17B
AUM Growth
-$39.3M
Cap. Flow
+$39.3M
Cap. Flow %
1.81%
Top 10 Hldgs %
30.27%
Holding
744
New
50
Increased
150
Reduced
186
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 21.46%
2 Miscellaneous 14.13%
3 Financials 13.51%
4 Healthcare 11.86%
5 Consumer Discretionary 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAB icon
551
Wabtec
WAB
$49.4B
$13K ﹤0.01%
122
AES icon
552
AES
AES
$10.5B
$12.9K ﹤0.01%
850
CDW icon
553
CDW
CDW
$18.5B
$12.9K ﹤0.01%
+64
New +$12.8K
PRU icon
554
Prudential Financial
PRU
$41.3B
$12.9K ﹤0.01%
136
+106
+353% +$10K
MBB icon
555
iShares MBS ETF
MBB
$39B
$12.9K ﹤0.01%
145
HOOD icon
556
Robinhood
HOOD
$93.7B
$12.8K ﹤0.01%
1,300
SHW icon
557
Sherwin-Williams
SHW
$83.7B
$12.8K ﹤0.01%
50
DXCM icon
558
DexCom
DXCM
$34.3B
$12.7K ﹤0.01%
136
DOC icon
559
Healthpeak Properties
DOC
$14.5B
$12.7K ﹤0.01%
690
+220
+47% +$4.52K
IDR icon
560
Idaho Strategic Resources
IDR
$512M
$12.6K ﹤0.01%
2,500
BKR icon
561
Baker Hughes
BKR
$62B
$12.4K ﹤0.01%
+352
New +$12.5K
WELL icon
562
Welltower
WELL
$172B
$12.3K ﹤0.01%
150
IAG icon
563
IAMGOLD
IAG
$11.8B
$12.3K ﹤0.01%
5,700
BIO icon
564
Bio-Rad Laboratories Class A
BIO
$10.4B
$12.2K ﹤0.01%
34
XT icon
565
iShares Future Exponential Technologies ETF
XT
$3.96B
$12K ﹤0.01%
229
XLRE icon
566
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.38B
$11.9K ﹤0.01%
350
DWX icon
567
State Street SPDR S&P International Dividend ETF
DWX
$527M
$11.8K ﹤0.01%
359
DKNG icon
568
DraftKings
DKNG
$12.5B
$11.8K ﹤0.01%
400
BDJ icon
569
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.75B
$11.7K ﹤0.01%
1,539
MRO
570
DELISTED
Marathon Oil Corporation
MRO
$11.2K ﹤0.01%
420
SPDW icon
571
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
$11.2K ﹤0.01%
362
-151
-29% -$4.88K
EXC icon
572
Exelon
EXC
$45.3B
$11.2K ﹤0.01%
297
-59
-17% -$2.4K
GSK icon
573
GSK
GSK
$102B
$11.2K ﹤0.01%
308
GNRC icon
574
Generac Holdings
GNRC
$10.8B
$10.9K ﹤0.01%
100
MAS icon
575
Masco
MAS
$14.4B
$10.7K ﹤0.01%
+200
New +$11.5K

Similar funds

Cambridge Trust's Q3 2023 Portfolio in Review

As of Q3 2023, Cambridge Trust held 744 positions worth $2.17B, down 1.8% from $2.21B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cambridge Trust's Q3 2023 filing shows 50 new, 150 increased, 186 reduced and 36 closed positions. Its largest new stake was Vanguard Short-Term Treasury ETF: 167,956 shares worth $9.67M. The largest sale was CVS Health, an estimated $22.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Miscellaneous and Financials.

  • Cambridge Trust's largest Q3 2023 buy was Vanguard Short-Term Treasury ETF: 167,956 shares worth $9.67M.
  • Cambridge Trust added most to iShares 7-10 Year Treasury Bond ETF in Q3 2023, an estimated $31.8M increase.
  • Cambridge Trust's biggest Q3 2023 reduction was CVS Health, cutting an estimated $22.1M.
  • Cambridge Trust fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $330K.
  • Cambridge Trust's ten largest holdings make up 30% of its $2.17B portfolio in Q3 2023.
  • Cambridge Trust opened 50 new positions and closed 36 in Q3 2023.
  • Cambridge Trust's portfolio value fell 1.8% quarter-over-quarter to $2.17B.

Based on Cambridge Trust's 13F filing for Q3 2023, filed 26 Oct 2023.